Showing 35,281 - 35,300 results of 63,864 for search '(( 01 ((1 decrease) OR (a decrease)) ) OR ( 50 ((nn decrease) OR (mean decrease)) ))', query time: 1.68s Refine Results
  1. 35281
  2. 35282
  3. 35283
  4. 35284

    LiCl administration shifts GC taste responses in the direction of a simple “good vs. bad” judgment. by Bradly T. Stone (13149987)

    Published 2022
    “…<p><b>(A)</b> The time course of average correlations (Spearman rank-correlation coefficient) between firing rates and known palatability shows the expected increase as responses reached the late epoch, but this rise reached a higher peak following LiCl (<i>n</i> = 174) than saline injection (<i>n</i> = 136, Kruskal–Wallis H-test, ** <i>p <</i> 0.01). …”
  5. 35285
  6. 35286
  7. 35287

    Image_1_Micro-biological degradation and transformation of dissolved organic matter following continuous cropping of tobacco.JPEG by Peng Chen (6514)

    Published 2024
    “…After 7 years of CC, the soil preferentially produced compounds with either high H/C ratios (H/C > 1.5), including carbohydrates, lipids, and aliphatic/proteins, or low O/C ratios (O/C < 0.1), such as unsaturated hydrocarbons. …”
  8. 35288
  9. 35289

    The dog Jack following the 3-down 1-up adaptive threshold procedure for C-4 in standard conditions. by Lauren S. Fernandez (18004244)

    Published 2024
    “…<p>After three correct responses, the concentration was decreased by a half-log. Once Jack responded incorrectly when presented with 0.01 dilution of C4, the concentration was increased by a half-log. …”
  10. 35290
  11. 35291

    Image 9_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  12. 35292

    Image 6_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  13. 35293

    Image 10_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  14. 35294

    Image 3_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  15. 35295

    Image 8_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  16. 35296

    Image 7_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  17. 35297

    Image 4_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  18. 35298

    Image 5_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  19. 35299

    Image 2_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  20. 35300

    Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model by Tatsuro Nishimura (2646928)

    Published 2019
    “…</p><p>Results</p><p>Four weeks after infusing BMSCs, a significant improvement was observed in the Vein group (n = 8) compared to outcome in the Control group (n = 10), along with a decrease in ICG t<sub>1/2</sub>. …”